ET
Healthcare & Life Sciences
Enlaza Therapeutics
Enlaza Therapeutics is a Healthcare & Life Sciences startup, most recent round Series A, 2 tracked investors.
series-a
series-a
Stage
2
Investors
About Enlaza Therapeutics
Enlaza Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Enlaza Therapeutics develops novel classes of protein therapeutics aimed at creating more efficacious and safer treatments for patients.
Explore Enlaza Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.